$ESCA
ESCALADE INC Stock $esca

$esca Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923013129 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$67.77M	$56.93M	$72.38M
YoY Change		-21.34%	22.28%
Cost Of Revenue	$51.12M	$45.88M	$52.26M
YoY Change		-12.21%	25.16%
Gross Profit	$16.65M	$11.05M	$20.12M
YoY Change		-45.07%	15.4%
Gross Profit Margin	24.56%	19.41%	27.8%
Selling, General & Admin	$9.769M	$10.28M	$10.53M
YoY Change		-2.31%	6.58%
% of Gross Profit	58.68%	93.04%	52.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.402M	$1.396M	$1.473M
YoY Change		-5.23%	29.89%
% of Gross Profit	8.42%	12.63%	7.32%
Operating Expenses	$10.39M	$10.28M	$10.53M
YoY Change		-2.31%	6.58%
Operating Profit	$6.258M	$149.0K	$9.023M
YoY Change		-98.35%	26.57%
Interest Expense	-$1.580M	$1.375M	$560.0K
YoY Change		145.54%	139.32%
% of Operating Profit	-25.25%	922.82%	6.21%
Other Income/Expense, Net	$7.000K	$18.00K	$43.00K
YoY Change		-58.14%	22.86%
Pretax Income	$4.685M	-$1.208M	$8.506M
YoY Change		-114.2%	22.74%
Income Tax	$1.043M	-$256.0K	$1.852M
% Of Pretax Income	22.26%		21.77%
Net Earnings	$3.642M	-$952.0K	$6.654M
YoY Change		-114.31%	22.27%
Net Earnings / Revenue	5.37%	-1.67%	9.19%
Basic Earnings Per Share	$0.27	-$0.07	$0.49
Diluted Earnings Per Share	$0.26	-$0.07	$0.49
COMMON SHARES
Basic Shares Outstanding	13.73M	13.61M	13.51M
Diluted Shares Outstanding	13.84M	13.65M	13.65M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$577.0K	$6.064M	$6.392M
YoY Change		-5.13%	8.34%
Cash & Equivalents	$577.0K	$6.064M	$6.392M
Short-Term Investments
Other Short-Term Assets	$3.925M	$4.879M	$12.72M
YoY Change		-61.63%	217.9%
Inventory	$111.7M	$122.5M	$114.6M
Prepaid Expenses	$3.925M	$4.879M	$12.72M
Receivables	$54.98M	$50.47M	$67.30M
Other Receivables	$1.518M	$175.0K	$0.00
Total Short-Term Assets	$172.7M	$184.0M	$201.0M
YoY Change		-8.44%	29.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.93M	$24.68M	$28.81M
YoY Change		-14.34%	51.95%
Goodwill	$42.33M	$42.33M	$38.84M
YoY Change		8.98%	18.79%
Intangibles	$29.88M	$30.50M	$36.21M
YoY Change		-15.76%	62.98%
Long-Term Investments
YoY Change
Other Assets	$3.278M	$376.0K	$294.0K
YoY Change		27.89%	151.28%
Total Long-Term Assets	$108.4M	$109.5M	$106.0M
YoY Change		3.3%	39.28%
TOTAL ASSETS
Total Short-Term Assets	$172.7M	$184.0M	$201.0M
Total Long-Term Assets	$108.4M	$109.5M	$106.0M
Total Assets	$281.1M	$293.6M	$307.1M
YoY Change		-4.39%	32.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.68M	$17.23M	$27.38M
YoY Change		-37.06%	20.61%
Accrued Expenses	$10.90M	$10.50M	$19.88M
YoY Change		-47.17%	62.99%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.143M	$7.143M	$7.143M
YoY Change		0.0%
Total Short-Term Liabilities	$32.72M	$35.87M	$56.09M
YoY Change		-36.05%	48.9%
LONG-TERM LIABILITIES
Long-Term Debt	$76.81M	$88.08M	$92.85M
YoY Change		-5.14%	97.94%
Other Long-Term Liabilities	$8.629M	$407.0K	$448.0K
YoY Change		-9.15%	0.0%
Total Long-Term Liabilities	$85.44M	$88.49M	$93.30M
YoY Change		-5.15%	97.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.72M	$35.87M	$56.09M
Total Long-Term Liabilities	$85.44M	$88.49M	$93.30M
Total Liabilities	$122.7M	$137.3M	$155.4M
YoY Change		-11.69%	72.6%
SHAREHOLDERS EQUITY
Retained Earnings	$144.7M	$142.6M	$138.0M
YoY Change		3.3%	7.86%
Common Stock	$13.74M	$13.73M	$13.59M
YoY Change		1.07%	-2.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$158.4M	$156.3M	$151.6M
YoY Change
Total Liabilities & Shareholders Equity	$281.1M	$293.6M	$307.1M
YoY Change		-4.39%	32.38%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$3.642M	-$952.0K	$6.654M
YoY Change		-114.31%	22.27%
Depreciation, Depletion And Amortization	$1.402M	$1.396M	$1.473M
YoY Change		-5.23%	29.89%
Cash From Operating Activities	$8.380M	$4.516M	-$2.872M
YoY Change		-257.24%	-71.96%
INVESTING ACTIVITIES
Capital Expenditures	$364.0K	$704.0K	$730.0K
YoY Change		-3.56%	-49.69%
Acquisitions		$0.00	$34.62M
YoY Change		-100.0%
Other Investing Activities		$0.00	-$34.62M
YoY Change		-100.0%	-86640.0%
Cash From Investing Activities	-$364.0K	-$704.0K	-$35.35M
YoY Change		-98.01%	2408.59%
FINANCING ACTIVITIES
Cash Dividend Paid		$2.059M	$2.038M
YoY Change		1.03%	4.51%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$34.89M	$30.38M
YoY Change		14.85%	-5.78%
Cash From Financing Activities	-13.50M	-$1.715M	$40.24M
YoY Change		-104.26%	186.89%
NET CHANGE
Cash From Operating Activities	8.380M	$4.516M	-$2.872M
Cash From Investing Activities	-364.0K	-$704.0K	-$35.35M
Cash From Financing Activities	-13.50M	-$1.715M	$40.24M
Net Change In Cash	-5.487M	$2.097M	$2.018M
YoY Change		3.91%	-15.0%
FREE CASH FLOW
Cash From Operating Activities	$8.380M	$4.516M	-$2.872M
Capital Expenditures	$364.0K	$704.0K	$730.0K
Free Cash Flow	$8.016M	$3.812M	-$3.602M
YoY Change		-205.83%	-69.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000033488
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	71000	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13594407
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10283000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	620000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	570000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	149000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9023000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1375000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	560000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1208000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8506000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-256000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1852000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-952000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6654000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	146615000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	388000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2038000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	151619000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	158475000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-952000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	459000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2059000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	395000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	156318000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6654000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1396000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1473000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	99000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	459000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	388000	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	395000	usd
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2023Q1	esca	Cash Flow Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities CashFlowAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	3218000	usd
CY2022Q1	esca	Cash Flow Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities CashFlowAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-11486000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4516000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2872000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	704000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	730000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	34616000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-704000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35346000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	35231000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	72830000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	34887000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	30376000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	-0	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	180000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2059000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2038000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1715000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40236000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2097000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2018000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3967000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4374000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6064000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	7311000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	7789000	usd
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	9395000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	3386000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3478000	usd
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	4318000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	111756000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	110603000	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	100892000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	122453000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	121870000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	114605000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	6064000	usd
CY2023Q1	esca	Long Term Debt Current Fair Value LongTermDebtCurrentFairValue	7143000	usd
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	88082000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	3967000	usd
CY2022Q4	esca	Long Term Debt Current Fair Value LongTermDebtCurrentFairValue	7143000	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	87738000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	6392000	usd
CY2022Q1	esca	Long Term Debt Current Fair Value LongTermDebtCurrentFairValue	7143000	usd
CY2022Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	92850000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	459000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	388000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2816000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3235000	usd
CY2022Q1	us-gaap	Assets Assets	307061000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2100000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13648000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13509000
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	138000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13648000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13647000
CY2023Q1	esca	Revenue From Contract With Customer Excluding Assessed Tax Gross RevenueFromContractWithCustomerExcludingAssessedTaxGross	62973000	usd
CY2022Q1	esca	Revenue From Contract With Customer Excluding Assessed Tax Gross RevenueFromContractWithCustomerExcludingAssessedTaxGross	80083000	usd
CY2023Q1	esca	Sales Returns SalesReturns	1512000	usd
CY2022Q1	esca	Sales Returns SalesReturns	2170000	usd
CY2023Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	440000	usd
CY2022Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	625000	usd
CY2023Q1	esca	Sales Allowances SalesAllowances	4090000	usd
CY2022Q1	esca	Sales Allowances SalesAllowances	4908000	usd
CY2023Q1	esca	Sales Return And Allowances Goods SalesReturnAndAllowancesGoods	6042000	usd
CY2022Q1	esca	Sales Return And Allowances Goods SalesReturnAndAllowancesGoods	7703000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56931000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72380000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	374000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	338000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	612000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	501000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	129000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	182000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	1115000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	1021000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	245000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	303000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y9M14D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y1M13D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0505	pure
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1091000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1402000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1367000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1323000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1237000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	5270000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11690000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2301000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	9389000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	991000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8398000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	9389000	usd

Files In Submission

Name	View Source	Status
esca-20230331_pre.xml	Edgar Link	unprocessable
0001437749-23-013129-index-headers.html	Edgar Link	pending
0001437749-23-013129-index.html	Edgar Link	pending
0001437749-23-013129.txt	Edgar Link	pending
0001437749-23-013129-xbrl.zip	Edgar Link	pending
esca-20230331.xsd	Edgar Link	pending
esca20230325_10q.htm	Edgar Link	pending
ex_504087.htm	Edgar Link	pending
ex_504088.htm	Edgar Link	pending
ex_504089.htm	Edgar Link	pending
ex_504090.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
esca-20230331_cal.xml	Edgar Link	unprocessable
esca-20230331_def.xml	Edgar Link	unprocessable
esca-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
esca20230325_10q_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESCA
ESCALADE INC Stock $esca

2023 Q2 Form 10-Q Financial Statement

#000143774923013129 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESCA ESCALADE INC Stock $esca

2023 Q2 Form 10-Q Financial Statement

#000143774923013129 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESCA
ESCALADE INC Stock $esca